Bed Bath & Beyond's (NASDAQ:BBBY) stock hit a five-year low recently after the release of a weak first-quarter earnings report. The home-goods retailer has certainly matured over the years, and though it's tried to give itself a bit of a face-lift recently with the purchase of a flash-sale site, that might not be enough to move the needle.
In this clip from the Motley Fool Money radio show, Jason Moser explains a few reasons the company is far from a buy, even at this discounted price.
A transcript follows the video.
This podcast was recorded on June 24, 2016.
Chris Hill: Bed Bath & Beyond stock hitting a five-year low after a first quarter that missed on just about everything you can measure, Jason. They missed on profit, revenue, same-store sales. This was not a good quarter.
Matt Argersinger: Did they miss on the "beyond part," too?
Jason Moser: I was going to say, let's not dismiss the "beyond" here; that's the real catalyst. Chris, I feel like we've been calling this one for the past four or five years we've been doing MarketFoolery and Motley Fool Money. This is, I think, to us in this room, not a big surprise at all. I don't think it's hyperbole to say that this is a business in decline, either. Certainly it has hit its growth limit. You see that top-line revenues are flat; it looks like they're starting to shrink. Margins are telling the tale -- they've fallen and they can't get up.
And I don't know what they do in the face of this new e-commerce market to really turn this around. I know one thing they tried to do, recently, is buy the web property One Kings Lane, which, a time ago, in 2014, just about hit unicorn status as a billion-dollar privately managed business. It's been a bit of a downfall since then, and One Kings Lane has more or less become irrelevant. It's so irrelevant that, with the purchase from Bed Bath & Beyond, when they were asked about the price, they said, "Well, we bought it for a price that was not material to our financials." That tells me all we need to know. It's not really something that's going to be leading this business forward. I don't think it's going to have a material effect on their financials in the years to come, because I think One Kings Lane is a business that has also become more or less irrelevant.
I don't see any reason in the world why you would need to invest in Bed Bath & Beyond today, and I'm going to keep that thumbs-down in CAPS for a little while longer
Jason Moser has no position in any stocks mentioned. Matthew Argersinger has no position in any stocks mentioned. Chris Hill has no position in any stocks mentioned. The Motley Fool recommends Bed Bath and Beyond. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.